Introduzione

Questa pagina fornisce un'analisi completa dello storico delle operazioni di insider trading note di Fenimore Christopher R.. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4. Nonostante queste restrizioni, la ricerca accademica suggerisce che gli insider, in generale, tendono a sovraperformare il mercato nelle proprie società.

Redditività media delle transazioni

La redditività media delle transazioni è il rendimento medio di tutti gli acquisti effettuati sul mercato aperto dagli insider negli ultimi tre anni. Pe calcolarla, esaminiamo tutti gli acquisti non pianificati effettuati dall'insider sul mercato aperto, escludendo tutte le operazioni che sono state parte di un piano di trading 10b5-1. Calcoliamo quindi la performance media di queste operazioni nell'arco di 3, 6 e 12 mesi e facciamo la media di ciascuna di queste durate per generare un indicatore di performance finale per ogni operazione. Infine, facciamo la media di tutti gli indicatori di performance per calcolare un indicatore di performance per l'insider. Questo elenco comprende solo gli insider che hanno effettuato almeno tre operazioni negli ultimi due anni.

Se la redditività delle operazioni di questo insider è "N/D", l'insider non ha effettuato acquisti sul mercato aperto negli ultimi tre anni, oppure le operazioni effettuate sono troppo recenti per poter calcolare un indicatore di performance affidabile.

Frequenza di aggiornamento: giornaliera

Vedi l'elenco degli insider trader più redditizi

Società con posizioni di insider dichiarate

I depositi SEC indicano che Fenimore Christopher R. ha dichiarato partecipazioni o transazioni nelle seguenti società:

Titolo Ruolo Ultime partecipazioni dichiarate
US:REGN / Regeneron Pharmaceuticals, Inc. EVP Finance CFO 18.300
Come interpretare i grafici

I grafici seguenti mostrano l'andamento dei titoli dopo ogni operazione di mercato aperto non pianificata effettuata da Fenimore Christopher R.. Per operazioni non pianificate si intendono operazioni non effettuate nell'ambito di un piano di trading 10b5-1. La performance dei titoli è rappresentata come variazione percentuale cumulativa del prezzo delle azioni. Ad esempio, se un'operazione di insider è stata effettuata il 1° gennaio 2019, il grafico mostrerà la variazione percentuale giornaliera del titolo fino ad oggi. Se il prezzo dell'azione passasse da 10 a 15 dollari durante questo periodo, la variazione percentuale cumulativa del prezzo dell'azione sarebbe del 50%. Una variazione di prezzo da 10 a 20 dollari sarebbe del 100%, mentre una variazione di prezzo da 10 a 5 dollari sarebbe del -50%.

In definitiva, cerchiamo di determinare la correlazione tra le operazioni dell'insider e i rendimenti in eccesso (positivi o negativi) del prezzo dell'azione, al fine di capire se l'insider sta programmando le proprie operazioni per trarre profitto da informazioni privilegiate. Immaginiamo che un insider stia facendo questo. In questa situazione, ci aspetteremmo (a) rendimenti positivi dopo gli acquisti, oppure (b) rendimenti negativi dopo le vendite. Nel caso (a), il grafico ACQUISTO mostrerebbe una serie di curve ascendenti, indicando rendimenti positivi dopo ogni operazione di acquisto. Nel caso (b), il grafico VENDITA mostrerebbe una serie di curve inclinate verso il basso, indicando rendimenti negativi dopo ogni operazione di vendita.

Tuttavia, questo non è sufficiente per trarre conclusioni. Se, ad esempio, il prezzo delle azioni della società è aumentato in maniera non ciclica per molti anni, allora ci aspetteremmo che tutti i grafici post-acquisto abbiano una pendenza rivolta verso l'alto. Allo stesso modo, ribassi non ciclici per molti anni darebbero luogo a grafici post-negoziazione rivolti verso il basso. Nessuno di questi grafici suggerisce un'attività di insider trading.

L'indicatore più forte sarebbe una situazione in cui il prezzo delle azioni fosse estremamente ciclico e vi fossero segnali positivi nel grafico ACQUISTO e curve negative nel grafico VENDITA. Questa situazione suggerirebbe che l'insider sta programmando le operazioni di trading per trarne un vantaggio finanziario.

Storico delle operazioni degli insider

Questa tabella mostra l'elenco completo delle operazioni effettuate da Fenimore Christopher R. come comunicato alla Securities Exchange Commission (SEC).

Data di deposito Data della transazione Modulo Ticker Titolo Codice 10b5-1 Azioni Azioni rimanenti Variazione
percentuale
Prezzo
dell'azione
Valore
della transazione
Valore
rimanente
2025-12-09 2025-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -992 18.300 -5,14 712,94 -707.236 13.046.802
2025-12-09 2025-12-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 3.027 19.292 18,61
2024-12-18 2024-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -491 16.265 -2,93 730,81 -358.828 11.886.625
2024-12-10 2024-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1.140 16.756 -6,37 787,00 -897.180 13.186.972
2024-12-10 2024-12-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2.591 17.896 16,93
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -200 25 -88,89 1.206,67 -241.334 30.167
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -235 225 -51,09 1.205,67 -283.332 271.276
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -200 25 -88,89 1.206,70 -241.340 30.168
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -236 225 -51,19 1.205,67 -284.538 271.276
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -450 0 -100,00 1.206,15 -542.768
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -928 450 -67,34 1.205,49 -1.118.695 542.470
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -2.237 1.378 -61,88 1.204,71 -2.694.936 1.660.090
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -200 0 -100,00 1.206,30 -241.260
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -766 200 -79,30 1.205,44 -923.367 241.088
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -228 966 -19,10 1.204,79 -274.692 1.163.827
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -600 14.372 -4,01 955,00 -573.000 13.725.260
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.100 14.972 -6,84 954,57 -1.050.027 14.291.822
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.342 16.072 -7,71 953,47 -1.279.557 15.324.170
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.046 17.414 -5,67 952,62 -996.441 16.588.925
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -487 18.460 -2,57 951,39 -463.327 17.562.659
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -344 18.947 -1,78 950,49 -326.969 18.008.934
2024-01-25 2024-01-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.583 19.291 -15,66 948,50 -3.398.476 18.297.514
2024-01-25 2024-01-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.000 22.874 27,97 399,66 1.998.300 9.141.823
2024-01-25 2024-01-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.986 17.874 -18,23 948,50 -3.780.721 16.953.489
2024-01-25 2024-01-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.000 21.860 29,66 555,67 2.778.350 12.146.946
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.469 16.860 -17,06 912,30 -3.164.769 15.381.378
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.000 20.329 32,62 399,66 1.998.300 8.124.688
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -4.043 15.329 -20,87 912,30 -3.688.429 13.984.647
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.000 19.372 34,79 555,67 2.778.350 10.764.439
2023-12-29 2023-12-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.448 14.372 -14,55 856,71 -2.097.226 12.312.636
2023-12-26 2023-12-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -250 16.820 -1,46 846,27 -211.568 14.234.261
2023-12-26 2023-12-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.224 17.070 -6,69 844,09 -1.033.166 14.408.616
2023-12-26 2023-12-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -456 18.294 -2,43 843,79 -384.768 15.436.294
2023-12-14 2023-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2.552 18.750 -11,98 856,71 -2.186.324 16.063.312
2023-12-12 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -260 21.302 -1,21 844,09 -219.463 17.980.805
2023-12-12 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1.276 21.562 -5,59 844,09 -1.077.059 18.200.269
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2.370 22.838 11,58
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -474 20.468 -2,26 843,79 -399.956 17.270.694
2023-08-25 2023-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -5.198 20.942 -19,89 842,66 -4.380.147 17.646.986
2023-08-25 2023-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 7.000 26.140 36,57 399,66 2.797.620 10.447.112
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.192 18.409 -10,64 806,47 -1.767.782 14.846.306
2023-02-07 2023-02-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.286 20.295 -13,93 774,29 -2.544.317 15.714.216
2023-02-07 2023-02-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.000 23.581 26,91 270,43 1.352.150 6.377.010
2022-12-20 2022-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 1.926 18.581 11,56
2022-12-13 2022-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -247 16.655 -1,46 753,28 -186.060 12.545.878
2022-12-13 2022-10-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift 435 460 1.740,00
2022-12-13 2022-10-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift 436 461 1.744,00
2022-12-13 2022-10-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift -871 0 -100,00
2022-10-07 2022-10-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.844 16.425 -10,09 749,00 -1.381.156 12.302.325
2022-10-05 2022-10-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.346 18.269 -15,48 724,00 -2.422.504 13.226.756
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -2.450 10.000 -19,68
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -5.000 5.000 -50,00
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.451 26.615 -11,48 736,21 -2.540.661 19.594.229
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.000 30.066 19,95 270,43 1.352.150 8.130.748
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2.155 25.066 -7,92 736,21 -1.586.533 18.453.840
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.450 27.221 9,89 555,67 1.361.392 15.125.893
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -2.000 12.450 -13,84
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -10.000 10.000 -50,00
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -6.857 24.771 -21,68 700,99 -4.806.688 17.364.223
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10.000 31.628 46,24 270,43 2.704.300 8.553.160
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1.797 21.628 -7,67 700,99 -1.259.679 15.161.012
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.000 23.425 9,33 555,67 1.111.340 13.016.570
2021-12-14 2021-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -270 21.122 -1,26 664,34 -179.372 14.032.189
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 7.941 7.941
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 1.859 21.392 9,52
2021-08-25 2021-08-20 4/A REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -8.719 19.020 -31,43 664,85 -5.796.827 12.645.447
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -14 27.739 -0,05 665,21 -9.313 18.452.260
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -70 27.753 -0,25 663,05 -46.414 18.401.627
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1 27.823 0,00 662,78 -663 18.440.528
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -88 27.824 -0,32 661,89 -58.246 18.416.427
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -23 27.912 -0,08 660,33 -15.188 18.431.131
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9 27.935 -0,03 659,33 -5.934 18.418.384
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.576 27.944 -14,07 655,00 -2.997.280 18.303.320
2021-08-24 2021-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -13.500 0 -100,00
2021-08-24 2021-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 13.500 32.520 70,98 179,13 2.418.255 5.825.308
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 10.000 10.000
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 1.750 21.102 9,04
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 969 19.352 5,27
2020-12-11 2020-09-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift 25 25
2020-12-11 2020-09-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift 25 25
2020-12-11 2020-09-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift -50 0 -100,00
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11 17.501 -0,06 658,00 -7.238 11.515.658
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -82 17.512 -0,47 647,79 -53.119 11.344.098
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -155 17.594 -0,87 646,82 -100.257 11.380.151
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -72 17.749 -0,40 645,33 -46.464 11.453.962
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -303 17.821 -1,67 644,57 -195.305 11.486.882
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -691 18.124 -3,67 643,49 -444.652 11.662.613
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -676 18.815 -3,47 642,39 -434.256 12.086.568
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -855 19.491 -4,20 641,58 -548.551 12.505.036
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -113 20.346 -0,55 640,61 -72.389 13.033.851
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -75 20.459 -0,37 639,64 -47.973 13.086.395
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -306 20.534 -1,47 638,51 -195.384 13.111.164
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -154 20.840 -0,73 637,88 -98.234 13.293.419
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -216 20.994 -1,02 636,56 -137.497 13.363.941
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -10.000 13.500 -42,55
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise -2.224 0 -100,00
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.224 21.210 11,71 52,03 115.715 1.103.556
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -6.291 18.986 -24,89 655,57 -4.124.191 12.446.652
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 10.000 25.277 65,46 179,13 1.791.300 4.527.869
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -294 15.277 -1,89 596,36 -175.330 9.110.592
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -403 15.571 -2,52 595,50 -239.986 9.272.530
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -747 15.974 -4,47 594,35 -443.979 9.494.147
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -109 16.721 -0,65 593,25 -64.664 9.919.733
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -214 16.830 -1,26 592,20 -126.731 9.966.726
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -233 17.044 -1,35 591,61 -137.845 10.083.401
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -153 17.277 -0,88 590,70 -90.377 10.205.524
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -147 17.430 -0,84 588,80 -86.554 10.262.784
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -373 17.577 -2,08 587,55 -219.156 10.327.366
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -413 17.950 -2,25 586,54 -242.241 10.528.393
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -130 18.363 -0,70 585,76 -76.149 10.756.311
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -99 18.493 -0,53 584,62 -57.877 10.811.378
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -111 18.592 -0,59 583,06 -64.720 10.840.252
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -18 18.703 -0,10 582,69 -10.488 10.898.051
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -112 18.721 -0,59 581,40 -65.117 10.884.389
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -7.226 0 -100,00
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise -2.180 0 -100,00
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.180 18.833 13,09 30,63 66.773 576.855
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -3.670 16.653 -18,06 587,90 -2.157.593 9.790.299
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7.226 20.323 55,17 52,03 375.969 1.057.406
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise X -1.200 2.180 -35,50
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -68 13.097 -0,52 497,99 -33.863 6.522.175
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -37 13.165 -0,28 494,16 -18.284 6.505.616
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -174 13.202 -1,30 493,24 -85.824 6.511.754
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -134 13.376 -0,99 492,45 -65.988 6.587.011
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -70 13.510 -0,52 491,65 -34.416 6.642.192
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -201 13.580 -1,46 489,48 -98.385 6.647.138
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -137 13.781 -0,98 488,76 -66.960 6.735.602
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3 13.918 -0,02 484,14 -1.452 6.738.261
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -124 13.921 -0,88 483,58 -59.964 6.731.917
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -62 14.045 -0,44 482,09 -29.890 6.770.954
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -58 14.107 -0,41 480,28 -27.856 6.775.310
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -69 14.165 -0,48 479,00 -33.051 6.785.035
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -63 14.234 -0,44 478,77 -30.163 6.814.812
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 1.200 14.297 9,16 30,63 36.756 437.917
2020-01-27 2020-01-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise -500 3.380 -12,89
2020-01-27 2020-01-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 500 13.097 3,97 30,63 15.315 401.161
2019-12-23 2019-12-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise -400 3.880 -9,35
2019-12-23 2019-12-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 400 12.597 3,28 30,63 12.252 385.846
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -51 12.197 -0,42 378,27 -19.292 4.613.759
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -346 12.248 -2,75 377,38 -130.573 4.622.150
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -470 12.594 -3,60 376,27 -176.847 4.738.744
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -624 13.064 -4,56 375,58 -234.362 4.906.577
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -191 13.688 -1,38 374,82 -71.591 5.130.536
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.100 7.226 -30,02
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -1.418 13.879 -9,27 377,16 -534.813 5.234.604
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3.100 15.297 25,42 52,03 161.293 795.903
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 6.120 6.120
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2.500 12.197 25,78
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 1.020 9.697 11,76
2019-04-18 2019-04-18 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -350 0 -100,00
2019-04-18 2019-04-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 350 1.897 22,62
2019-04-18 2019-04-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -350 7.096 -4,70
2019-04-18 2019-04-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 350 7.446 4,93 21,25 7.438 158.228
2019-01-18 2019-01-18 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -150 350 -30,00
2019-01-18 2019-01-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 150 1.547 10,74
2019-01-18 2019-01-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -150 7.096 -2,07
2019-01-18 2019-01-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 150 7.246 2,11 21,25 3.188 153.978
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -675 500 -57,45
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 7.096 -2,74 362,45 -72.490 2.571.945
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -100 7.296 -1,35 361,65 -36.165 2.638.598
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -500 7.396 -6,33 360,40 -180.200 2.665.518
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 7.896 -2,47 359,38 -71.876 2.837.664
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 8.096 -2,41 358,27 -71.654 2.900.554
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 8.296 -2,35 357,50 -71.500 2.965.820
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -348 8.496 -3,93 356,27 -123.982 3.026.870
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -100 8.844 -1,12 355,14 -35.514 3.140.858
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 675 8.944 8,16 21,25 14.344 190.060
2018-12-20 2018-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.450 10.326 -25,04
2018-12-20 2018-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -1.602 8.269 -16,23 364,42 -583.801 3.013.389
2018-12-20 2018-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 3.450 9.871 53,73 52,03 179.504 513.588
2018-12-14 2018-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 11.400 11.400
2018-12-14 2018-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
A - Award 5.000 6.421 351,86
2018-12-14 2018-10-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 2.950 2.950
2018-12-14 2018-10-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -2.950 1.397 -67,86
2018-12-14 2018-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 50 4.347 1,16
2018-12-14 2018-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -50 1.421 -3,40
2018-08-31 2018-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -50 1.175 -4,08
2018-08-31 2018-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 50 200 33,33 21,25 1.062 4.250
2018-01-17 2018-01-16 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -150 1.225 -10,91
2018-01-17 2018-01-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 150 150 21,25 3.188 3.188
2017-12-13 2017-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 12.300 12.300
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
9.648
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
11.015
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
12.617
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
9.648
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
11.015
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
12.617
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)